Avinger announces successful completion of first cases with the lightbox 3 next generation imaging console

Redwood city, ca / accesswire / february 28, 2022 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of peripheral artery disease (pad), today announced that physicians in the u.s. have successfully completed first cases with its new lightbox 3 imaging console. the lightbox 3 received 510(k) pre-marketing clearance from the u.s. food & drug administration (fda) in january.
AVGR Ratings Summary
AVGR Quant Ranking